EP-1365: F-FDG-PET/CT metabolic features as prognostic and predictive factors in lung tumors undergoing SBRT

Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Cinzia Iotti(Azienda Sanitaria Unità Locale di Reggio Emilia), Elisabetta Lattanzi(University of Parma), Lucia Giaccherini(Azienda Sanitaria Unità Locale di Reggio Emilia), A. Botti(Azienda Sanitaria Unità Locale di Reggio Emilia), M. Galaverni(Azienda Ospedaliera S.Maria), Ilaria Renna(Azienda Sanitaria Unità Locale di Reggio Emilia), Martina Orlandi(University of Modena and Reggio Emilia), Frank J. Bellafiore, Giorgia Timon(Azienda Sanitaria Unità Locale di Reggio Emilia)
Radiotherapy and Oncology
April 1, 2018
10.1016/s0167-8140(18)31674-8
Cited by 0

Related Papers

Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|Lung Cancer|2009|277
Stereotactic body radiation therapy for lung metastases
|Lung Cancer|2011|146
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
|European Urology|2021|110
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin’s lymphoma: dosimetric comparison and clinical considerations
|Radiation Oncology|2012|109
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
|Neuro-Oncology|2021|91